103 related articles for article (PubMed ID: 24926091)
1. Utility of CD279/PD-1 immunohistochemistry in the evaluation of benign and neoplastic T-cell-rich bone marrow infiltrates.
Cogbill CH; Swerdlow SH; Gibson SE
Am J Clin Pathol; 2014 Jul; 142(1):88-98. PubMed ID: 24926091
[TBL] [Abstract][Full Text] [Related]
2. Bone Marrow Infiltration of Angioimmunoblastic T-Cell Lymphoma: Identification and Prognostic Impact of Histologic Patterns and Diagnostic Application of Ancillary Phenotypic and Molecular Analyses.
Gerlach MM; Juskevicius D; Vela V; Dirnhofer S; Tzankov A
Arch Pathol Lab Med; 2020 May; 144(5):602-611. PubMed ID: 31556696
[TBL] [Abstract][Full Text] [Related]
3. Myeloid cell nuclear differentiation antigen is expressed in a subset of marginal zone lymphomas and is useful in the differential diagnosis with follicular lymphoma.
Metcalf RA; Monabati A; Vyas M; Roncador G; Gualco G; Bacchi CE; Younes SF; Natkunam Y; Freud AG
Hum Pathol; 2014 Aug; 45(8):1730-6. PubMed ID: 24925224
[TBL] [Abstract][Full Text] [Related]
4. Peripheral T-cell lymphoma with follicular T-cell markers.
Rodríguez-Pinilla SM; Atienza L; Murillo C; Pérez-Rodríguez A; Montes-Moreno S; Roncador G; Pérez-Seoane C; Domínguez P; Camacho FI; Piris MA
Am J Surg Pathol; 2008 Dec; 32(12):1787-99. PubMed ID: 18779728
[TBL] [Abstract][Full Text] [Related]
5. Expression of programmed death-1 (CD279) in primary cutaneous B-cell lymphomas with correlation to lymphoma entities and biological behaviour.
Mitteldorf C; Bieri M; Wey N; Kerl K; Kamarachev J; Pfaltz M; Kutzner H; Roncador G; Tomasini D; Kempf W
Br J Dermatol; 2013 Dec; 169(6):1212-8. PubMed ID: 23937075
[TBL] [Abstract][Full Text] [Related]
6. Programmed death 1 is a marker of angioimmunoblastic T-cell lymphoma and B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia.
Xerri L; Chetaille B; Serriari N; Attias C; Guillaume Y; Arnoulet C; Olive D
Hum Pathol; 2008 Jul; 39(7):1050-8. PubMed ID: 18479731
[TBL] [Abstract][Full Text] [Related]
7. Spectrum of bone marrow findings in patients with angioimmunoblastic T-cell lymphoma.
Grogg KL; Morice WG; Macon WR
Br J Haematol; 2007 Jun; 137(5):416-22. PubMed ID: 17488486
[TBL] [Abstract][Full Text] [Related]
8. The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation.
Marafioti T; Paterson JC; Ballabio E; Chott A; Natkunam Y; Rodriguez-Justo M; Plonquet A; Rodriguez-Pinilla SM; Klapper W; Hansmann ML; Pileri SA; Isaacson PG; Stein H; Piris MA; Mason DY; Gaulard P
Haematologica; 2010 Mar; 95(3):432-9. PubMed ID: 20207847
[TBL] [Abstract][Full Text] [Related]
9. Large B-cell lymphomas poor in B cells and rich in PD-1+ T cells can mimic T-cell lymphomas.
Ohgami RS; Zhao S; Natkunam Y
Am J Clin Pathol; 2014 Aug; 142(2):150-6. PubMed ID: 25015854
[TBL] [Abstract][Full Text] [Related]
10. Follicular peripheral T-cell lymphoma expands the spectrum of classical Hodgkin lymphoma mimics.
Moroch J; Copie-Bergman C; de Leval L; Plonquet A; Martin-Garcia N; Delfau-Larue MH; Molinier-Frenkel V; Belhadj K; Haioun C; Audouin J; Swerdlow SH; Marafioti T; Gaulard P
Am J Surg Pathol; 2012 Nov; 36(11):1636-46. PubMed ID: 23073322
[TBL] [Abstract][Full Text] [Related]
11. p27(Kip1) immunostaining for the differential diagnosis of small b-cell neoplasms in trephine bone marrow biopsies.
Kremer M; Dirnhofer S; Nickl A; Hoefler H; Quintanilla-Martínez L; Fend F
Mod Pathol; 2001 Oct; 14(10):1022-9. PubMed ID: 11598173
[TBL] [Abstract][Full Text] [Related]
12. Use of CD137 ligand expression in the detection of small B-cell lymphomas involving the bone marrow.
Zhao S; Xing Y; Natkunam Y
Hum Pathol; 2014 May; 45(5):1024-30. PubMed ID: 24746207
[TBL] [Abstract][Full Text] [Related]
13. Utility of BCL2, PD1, and CD25 immunohistochemical expression in the diagnosis of T-cell lymphomas.
O'Malley DP; Chizhevsky V; Grimm KE; Hii A; Weiss LM
Appl Immunohistochem Mol Morphol; 2014; 22(2):99-104. PubMed ID: 23702649
[TBL] [Abstract][Full Text] [Related]
14. bcl-2 expression by multicolor flow cytometric analysis assists in the diagnosis of follicular lymphoma in lymph node and bone marrow.
Cook JR; Craig FE; Swerdlow SH
Am J Clin Pathol; 2003 Jan; 119(1):145-51. PubMed ID: 12520710
[TBL] [Abstract][Full Text] [Related]
15. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
Carbone A; Gloghini A; Gruss HJ; Pinto A
Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
[TBL] [Abstract][Full Text] [Related]
16. Benign lymphoid aggregates in the bone marrow: distribution patterns of B and T lymphocytes.
Naemi K; Brynes RK; Reisian N; Johnston A; Dhillon R; Walavalkar V; Zhao X; Rezk SA
Hum Pathol; 2013 Apr; 44(4):512-20. PubMed ID: 23063505
[TBL] [Abstract][Full Text] [Related]
17. Focal lymphoid aggregates (nodules) in bone marrow biopsies: differentiation between benign hyperplasia and malignant lymphoma--a practical guideline.
Thiele J; Zirbes TK; Kvasnicka HM; Fischer R
J Clin Pathol; 1999 Apr; 52(4):294-300. PubMed ID: 10474523
[TBL] [Abstract][Full Text] [Related]
18. The usefulness of immunohistochemistry in the diagnosis of follicular lymphoma in bone marrow biopsy specimens.
West RB; Warnke RA; Natkunam Y
Am J Clin Pathol; 2002 Apr; 117(4):636-43. PubMed ID: 11939740
[TBL] [Abstract][Full Text] [Related]
19. T-cell lymphoid aggregates in bone marrow after rituximab therapy for B-cell follicular lymphoma: a marker of therapeutic efficacy?
Raynaud P; Caulet-Maugendre S; Foussard C; Salles G; Moreau A; Rossi JF; Patey M; Rousselet MC; Bene MC; Damotte D; Cornillet Lefebvre P; Martin A; Costes V;
Hum Pathol; 2008 Feb; 39(2):194-200. PubMed ID: 17949786
[TBL] [Abstract][Full Text] [Related]
20. Germinal-center T-helper-cell markers PD-1 and CXCL13 are both expressed by neoplastic cells in angioimmunoblastic T-cell lymphoma.
Yu H; Shahsafaei A; Dorfman DM
Am J Clin Pathol; 2009 Jan; 131(1):33-41. PubMed ID: 19095563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
